GENE ONLINE|News &
Opinion
Blog

IPO
Biotech and Pharma IPOs Surge with Innovative Therapies in the Beginning of 2024: From Kymera Therapeutics to Kyverna Therapeutics Lead the Way
2024-01-18
Exploring AI’s Impact on Biotech Breakthroughs and International Funding
2023-08-29
GeneOnline’s Weekly News Highlights: July 10-14
2023-07-17
A Multi-Billion Budding Venture in Consumer Health, J&J’s Kenvue Aims to Raise $3.5 Billion in IPO
2023-04-27
Soon-To-Be J&J Spinoff, Kenvue Files for $100 Million IPO
2023-01-06
Alkermes to Break Oncology Sector into Independent Company
2022-11-03
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
BIO CEO 2022: Trends and Opportunities in Biotechnology Investments
2022-02-26
Biotech Showcase 2022: The China Factor
2022-01-24
APAC CRO Novotech Mulls IPO after $255 Million Round
2022-01-20
Top 10 Biotech IPOs on NASDAQ in 2021
2022-01-19
GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021
2022-01-07
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
1 2
LATEST
Cortisol: New Discoveries on its Impact Across Health, Culture, and Evolution
2024-02-26
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
EVENT
Scroll to Top